These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 62831)

  • 1. Influence of dimercaprol on the early hepatic uptake of 111In-bleomycin in the BALB/c mouse.
    Levine G; Sartiano GP; Boggs SS; Fried A; Gumerman LW
    J Nucl Med; 1976 Dec; 17(12):1083-7. PubMed ID: 62831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of dimercaprol (2,3-dimercapto-1-propanol) on the pharmacokinetics of 111In-bleomycin in the P-1798 lymphoma-bearing BALB/c mouse.
    Sartiano GP; Levine G; Boggs SS
    Oncology; 1980; 37(2):120-4. PubMed ID: 6153783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of 111In-bleomycin and 111 In-chlorides in mice.
    Konikowski T; Haynie TP; Glenn HJ
    J Nucl Med; 1975 Aug; 16(8):738-43. PubMed ID: 51922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Distribution study using 57Co-, 51Cr-, 111In- and 99mTc-bleomycin in mice with a solid Ehrlich carcinoma].
    Zimmermann M; Hale T
    Nuklearmedizin; 1976 Aug; 15(4):176-82. PubMed ID: 62345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice.
    Krohn KA; Meyers JM; DeNardo GL; DeNardo SJ
    J Nucl Med; 1977 Mar; 18(3):276-81. PubMed ID: 65460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Positive tumor scintigraphy. II. Clinical results with 111In-bleomycin].
    Weiss ML; Deckart H
    Radiobiol Radiother (Berl); 1978 Jun; 19(3):378-86. PubMed ID: 82977
    [No Abstract]   [Full Text] [Related]  

  • 7. [Affinity of 111In-bleomycin for malignant tumors (author's transl)].
    Akiba H; Kakehi H; Kawana M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1974 Mar; 34(3):162-8. PubMed ID: 4137371
    [No Abstract]   [Full Text] [Related]  

  • 8. [Positive tumor scintigraphy. I. Pharmacokinetics of 111In and 57Co bleomycin].
    Blottner A; Deckart H; Weiland J
    Radiobiol Radiother (Berl); 1978 Jun; 19(3):365-77. PubMed ID: 82976
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice.
    Adams GP; DeNardo SJ; Deshpande SV; DeNardo GL; Meares CF; McCall MJ; Epstein AL
    Cancer Res; 1989 Apr; 49(7):1707-11. PubMed ID: 2493983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of decreasing liver uptake of 111In-labeled anti-carcinoembryonic antigen monoclonal antibody by specific antibody pretreatment in tumor bearing mice.
    Beatty BG; O'Conner-Tressel M; Do T; Paxton RJ; Beatty JD
    Cancer Res; 1990 Feb; 50(3 Suppl):846s-851s. PubMed ID: 2297732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability, characterization, and kinetics of 111In-labeled monoclonal antitumor antibodies in normal animals and nude mouse-human tumor models.
    Halpern SE; Hagan PL; Garver PR; Koziol JA; Chen AW; Frincke JM; Bartholomew RM; David GS; Adams TH
    Cancer Res; 1983 Nov; 43(11):5347-55. PubMed ID: 6616469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and metabolism of 111In-labeled monoclonal antibody B6.2 by the rat liver.
    Jones PL; Brown BA; Sands H
    Cancer Res; 1990 Feb; 50(3 Suppl):852s-856s. PubMed ID: 2297733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution of indium-111-labeled OC 125 monoclonal antibody after intraperitoneal injection in nude mice intraperitoneally grafted with ovarian carcinoma.
    Thédrez P; Saccavini JC; Nolibé D; Simoen JP; Guerreau D; Gestin JF; Kremer M; Chatal JF
    Cancer Res; 1989 Jun; 49(11):3081-6. PubMed ID: 2720666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse.
    Goodwin DA; Meares CF; McCall MJ; Haseman MK; McTigue M; Diamanti CI; Chaovapong W
    J Nucl Med; 1985 May; 26(5):493-502. PubMed ID: 3921673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
    J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indium-111- and yttrium-90-labeled human monoclonal immunoglobulin M targeting of human ovarian cancer in mice.
    Borchardt PE; Quadri SM; Freedman RS; Vriesendorp HM
    J Nucl Med; 1998 Mar; 39(3):476-84. PubMed ID: 9529295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of radiolabeled human and mouse monoclonal IgM antibodies in murine models.
    Halpern SE; Hagan PL; Chen A; Birdwell CR; Bartholomew RM; Burnett KG; David GS; Poggenburg K; Merchant B; Carlo DJ
    J Nucl Med; 1988 Oct; 29(10):1688-96. PubMed ID: 3171697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.
    Grove RB; Reba RC; Eckelman WC; Goodyear M
    J Nucl Med; 1974 Jun; 15(6):386-90. PubMed ID: 4133503
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of indium bleomycin-111 in the scintillography of tumours].
    Bennett LR
    Gac Med Mex; 1974 Feb; 107(2):174-8. PubMed ID: 4134004
    [No Abstract]   [Full Text] [Related]  

  • 20. [Localization diagnostics of malignant tumors using radioactive bleomycin (author's transl)].
    Firusian N; Makoski HB
    Strahlentherapie; 1977 May; 153(5):331-41. PubMed ID: 69344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.